PeptideStack
5.2kquestions
20kanswers
220users

What does a 99.4% purity with a list of related substances attached let me conclude?

Asked 15 Jul 2024Modified 23 months agoViewed 16k times
14

The specifics, since they change the answer: 99.4% · list of related substances.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What is the correct interpretation, and what is the common misreading?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
shareeditfollowflag
LB
askedliam_bracken12k1615 Jul 2024
6Is there a reason to prefer the second method over the first, other than cost? – esben_lykke 4 months ago
add a comment

5 Answers

Accepted answer first, then by votes
-3

Accepted answer

The honest answer is that the achievable range of plausible purity figures for a given vial is wider than most people expect.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

What each test answers

TestAnswersDoes NOT answer
RP-HPLC, area %What fraction of detected material is the targetHow much target is present
Quantified contentMilligrams of peptide per vialWhat the impurities are
ESI-MS identityWhether the molecular weight matchesPurity, or isomeric substitution
Peptide mappingSequence, localised to a fragmentQuantity
Karl FischerWater content of the solidSolvent content
LAL endotoxinPyrogen load in EU/mgSterility
Sterility testGrowth in defined media over 14 daysEndotoxin, or bioburden count

The relevant detail is that mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.

Inter-laboratory studies on identical peptide material routinely find half-a-per-cent to a full-per-cent spreads in reported purity on the same sample.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
MS
answered · acceptedmarta_szymanska17k3820 Aug 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
65

Start from what the detector sees, because that tells you what the number means.

Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.

Mechanically, mass on column affects detector linearity and peak overlap — overloading broadens peaks and hides neighbours, while underloading improves resolution but loses sensitivity.

Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
DH
answeredDr_Wren_Halliday40k3812 Sept 2024
Worth adding that the method section is where the answer usually is. – lyoph_cake 6 months ago
add a comment
45

Understanding purity requires separating the chemistry from the method from the reporting convention, and the three are not independent.

The fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.

Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

Proline conformer interconversion kinetics are well-characterised and the half-life is of the same order as the chromatographic peak width at room temperature.

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
DL
answeredDr_Otto_Lindqvist38k381 Sept 2024
7I have seen exactly this failure mode twice and both times it was the diluent. – Dr_Tomas_Kral 5 months ago
8The distinction between purity and content cannot be repeated often enough here. – Dr_Ilse_Vandenberg 7 months ago
add a comment
26

Identity and purity are orthogonal, and a high purity says almost nothing about whether the peak is actually what you think it is.

Integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

edited 30 Aug 2024 by vialroom — expanded the table to cover the lower concentration

shareimprove this answerflag
VI
answeredvialroom87k1489 Aug 2024
25

Concretely, area percentage is not mass percentage, and conflating the two is the most common misreading of a purity figure.

Column pore size affects mass transfer — a 100 Angstrom packing on a 5 kDa peptide restricts diffusion, broadening the peak and potentially hiding small impurities in the shoulders.

One qualification: achieving purity above roughly 98 per cent on a 30-residue peptide is fighting the chemistry of synthesis, not the quality of the purification.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
C3
answeredcharge_state_339k4829 Jul 2024
4Do you have a reference for the last claim? Not disputing it, just want to read it. – Dr_Hanne_Solberg 25 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.